Miranda So, Jonathan Hand, Graeme Forrest, Stephanie M Pouch, Helen Te, Monica I Ardura, Rachel M Bartash, Darshana M Dadhania, Jeffrey Edelman, Dilek Ince, Margaret R Jorgenson, Sarah Kabbani, Erika D Lease, Deborah Levine, Linda Ohler, Gopi Patel, Jennifer Pisano, Michael L Spinner, Lilian Abbo, Elizabeth C Verna, Shahid Husain
Antimicrobial stewardship programs (ASPs) have made immense strides in optimizing antibiotic, antifungal, and antiviral use in clinical settings. However, although ASPs are required institutionally by regulatory agencies in the United States and Canada, they are not mandated for transplant centers or programs specifically. Despite the fact that solid organ transplant recipients in particular are at increased risk of infections from multidrug-resistant organisms, due to host and donor factors and immunosuppressive therapy, there currently are little rigorous data regarding stewardship practices in solid organ transplant populations, and thus, no transplant-specific requirements currently exist...
January 2022: American Journal of Transplantation